Lung Cancer Screening Does Not Increase Unnecessary Surgery Rates
the ONA take:
Lung cancer screening programs result in a low incidence of surgical intervention for non-lung cancer diagnoses and a rare incidence of surgical intervention for benign disease, a new study published in the journal The Annals of Thoracic Surgery has shown.
For the study, researchers at Lahey Hospital & Medical Center retrospectively analyzed the surgical outcomes of 25 of the 1,654 patients who underwent low-dose computer tomography lung cancer screening.
Results showed that of the 25 that underwent surgery, five had non-lung cancer diagnoses, equating to an incidence of surgery for non-lung cancer diagnosis of 0.30%.
Researchers found that the incidence of surgery for benign disease was 0.24%. The other 20 patients had lung cancer, of which 18 had early stage disease and two had late stage disease.
“Lung cancer screening saves lives, and our study serves as a model for how to set up a screening program that is safe and effective for patients,” said Christina Williamson, MD, from Lahey Hospital & Medical Center.
“It is only by minimizing the number of operations for benign disease and maintaining a low morbidity and mortality for surgical resection that the full benefit of lung cancer screening can be realized in its widespread adoption in clinical practice,” Williamson said.
Lung cancer screening programs result in a low incidence of surgical intervention for non-lung cancer diagnoses.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|